ArticleFrontiers in pediatrics2022

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.

Mikhail M Kostik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.